申请人:Ortho Pharmaceutical Corporation
公开号:US04555571A1
公开(公告)日:1985-11-26
The synthesis of substituted 2(1H)-quinazolinone-1-alkanoic acids and their esters is described. The novel quinazolinones are renal vasodilators and as such reduce vascular resistance to renal blood flow. The quinazolinones are useful as cardiovascular agents.
描述了取代的2(1H)-喹唑啉酮-1-烷酸及其酯的合成。这种新型喹唑啉酮是肾脏血管扩张剂,可以减少对肾脏血流的血管阻力。这些喹唑啉酮可用作心血管药物。